9 f e b r u a r y 2 0 1 7 | V O L 5 4 2 | N a T u r e | 2 3 7 LeTTer CRISPR-Cas systems provide microbes with adaptive immunity by employing short DNA sequences, termed spacers, that guide Cas proteins to cleave foreign DNA 1,2 . Class 2 CRISPR-Cas systems are streamlined versions, in which a single RNA-bound Cas protein recognizes and cleaves target sequences 3,4 . The programmable nature of these minimal systems has enabled researchers to repurpose them into a versatile technology that is broadly revolutionizing biological and clinical research 5 . However, current CRISPR-Cas technologies are based solely on systems from isolated bacteria, leaving the vast majority of enzymes from organisms that have not been cultured untapped. Metagenomics, the sequencing of DNA extracted directly from natural microbial communities, provides access to the genetic material of a huge array of uncultivated organisms 6,7 . Here, using genome-resolved metagenomics, we identify a number of CRISPR-Cas systems, including the first reported Cas9 in the archaeal domain of life, to our knowledge. This divergent Cas9 protein was found in littlestudied nanoarchaea as part of an active CRISPR-Cas system. In bacteria, we discovered two previously unknown systems, CRISPR-CasX and CRISPR-CasY, which are among the most compact systems yet discovered. Notably, all required functional components were identified by metagenomics, enabling validation of robust in vivo RNA-guided DNA interference activity in Escherichia coli.
The CRISPR-Cas locus in ARMAN-1 includes large CRISPR arrays adjacent to the cas1, cas2, cas4 and cas9 genes. This system was found on highly similar contigs (an average nucleotide identity of 99.7% outside the CRISPR array) reconstructed independently from 16 different samples. We reconstructed numerous alternative ARMAN-1 CRISPR arrays with a largely conserved end (probably comprised of the oldest spacers) and a variable region into which many distinct spacers have been incorporated ( Fig. 2a , Extended Data Fig. 2 and Supplementary  Table 1 ). Given the polarity of the array, we predict that the approximately 200-bp region between the end of the Cas9 gene and the variable end of the array is likely to contain the leader sequence and transcriptional start site. On the basis of the hypervariability in spacer content, we conclude that the ARMAN-1 CRISPR-Cas9 system is active in the sampled populations. Phylogenetic analysis of Cas1 (Extended Data Fig. 3a ) suggests that this archaeal CRISPR-Cas system does not clearly fall into any existing type II subtype. The presence of cas4 affiliates it 1 Department of Earth and Planetary Sciences, University of California, Berkeley, California 94720, USA. 2 Department of Molecular and Cell Biology, University of California, Berkeley, California 94720, USA. 3 Department of Chemistry, University of California, Berkeley, California 94720, USA. 4 Howard Hughes Medical Institute, University of California, Berkeley, California 94720, USA. 5 Innovative Genomics Initiative, University of California, Berkeley, California 94720, USA. 6 MBIB Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA. 7 a, Percentage of lineages with and without isolated representatives in Bacteria and Archaea, based on 31 major lineages described previously 29 .
The results highlight the massive scale of as-yet little-investigated biology in these domains. Archaeal Cas9 and the novel CRISPR-CasY were found exclusively in lineages with no isolated representatives. b, Locus organization of the discovered CRISPR-Cas systems.
letter reSeArCH with type II-B systems 3, 11 , yet the Cas9 sequence is more similar to type II-C proteins (Extended Data Fig. 4, Supplementary Data 3) . Thus, the archaeal type II system may have arisen as a fusion of type II-C and II-B systems (Extended Data Fig. 3b ).
Of the spacers of the ARMAN-1 CRISPR-Cas9 system, 56 target a 10-kbp circular sequence that encodes mostly short hypothetical proteins, and is probably an ARMAN-1 virus (Fig. 2b) . Indeed, cryoelectron tomographic reconstructions have often identified viral particles attached to ARMAN cells 12, 14 . ARMAN-1 protospacers also derived from a putative transposon within the genome of ARMAN-2 (another nanoarchaeon 13 ) and a putative mobile element in the genomes of Thermoplasmatales archaea, including that of I-plasma 15 from the same ecosystem (Extended Data Fig. 5 ). Direct cytoplasmic 'bridges' were observed between ARMAN and Thermoplasmatales cells, implying a close relationship between them 12, 14 . The ARMAN-1 CRISPR-Cas9 may therefore defend against transposon propagation between these organisms, a role that is reminiscent of piwi-interacting-RNA-mediated defence against transposition in the eukaryotic germ line 16 .
Unlike the ARMAN-1 CRISPR-Cas system, the ARMAN-4 cas9 gene has only one adjacent CRISPR repeat-spacer unit and no other cas genes in its vicinity (Extended Data Fig. 6 ). The lack of a typical CRISPR array and of cas1 points to a system with no capacity to acquire additional spacers. No target could be identified for the spacer sequence, but given the conservation of the locus in samples collected over several years, we cannot rule out the possibility that it is functional as a 'single-target' CRISPR-Cas system. Conservation of a single spacer may indicate that the ARMAN-4 Cas9 exerts an alternative role, such as gene regulation 17 or involvement in cell-cell interactions 18 .
Active DNA-targeting CRISPR-Cas systems use 2-4-nucleotide protospacer-adjacent motifs (PAMs) located next to target sequences for self-versus-non-self discrimination 19, 20 . Examining sequences adjacent to the genomic target sequences revealed a strong 'NGG' PAM preference in ARMAN-1 (Fig. 2c ). Cas9 also employs two separate transcripts, CRISPR RNA (crRNA) and trans-activating CRISPR RNA (tracrRNA), for RNA-guided DNA cleavage 21 . We identified a putative tracrRNA in the vicinity of both ARMAN-1 and ARMAN-4 CRISPR-Cas9 systems (Extended Data Fig. 7a-d ). It has previously been suggested that type II CRISPR systems were absent from archaea owing to a lack of the host factor, RNase III, responsible for crRNA-tracrRNA guide complex maturation 11, 22 . Notably, no RNase III homologues were identified in the ARMAN-1 genome (estimated to be 95% complete) and no internal promoters have been predicted for the CRISPR array 23 , suggesting an as-yet-undetermined mechanism of guide RNA production. Biochemical experiments to test the cleavage activity of ARMAN-1 and ARMAN-4 Cas9 proteins purified from both E. coli and yeast did not reveal any detectable activity, nor did in vivo E. coli-targeting assays (see Extended Data Table 2 and Extended Data Fig. 7e -g). Given the unique physiology and ecological niche of these nanoarchaea, the lack of activity may be due to a post-translational modification or a co-factor absent from the experimental expression systems.
In addition to Cas9, only three families of class 2 Cas effector proteins have been discovered and experimentally validated: Cpf1, C2c1, and C2c2 (refs 4, 24, 25) . Another gene, c2c3, which was identified only on small DNA fragments, has been suggested to encode such a protein as well 4 . We hypothesized that other distinct types of effector protein might exist within uncultivated microbes whose genomes were reconstructed from our metagenomic datasets. Indeed, a new type of class 2 CRISPR-Cas system was found in the genomes of two bacteria recovered from groundwater and sediment samples 26 . This system includes Cas1, Cas2, Cas4 and an uncharacterized protein of approximately 980 amino acids that we refer to as CasX. The high conservation (68% protein sequence identity; Supplementary Data 1) of this protein in two organisms belonging to different phyla, Deltaproteobacteria and Planctomycetes, suggests a recent cross-phylum transfer 27, 28 . The CRISPR arrays associated with each CasX had highly similar repeats (86% identity) of 37 nucleotides, spacers of 33-34 nucleotides and a putative tracrRNA between the Cas operon and the CRISPR array ( Fig. 1b , Extended Data Table 1 ). BLAST (https://blast.ncbi.nlm.nih. gov/Blast.cgi) searches revealed only weak similarity (e > 1 × 10 −4 ) to transposases, with similarity restricted to specific regions of the CasX C terminus. Distant homology detection and protein modelling identified a RuvC domain near the CasX C-terminal end, with organization reminiscent of that found in type V CRISPR-Cas systems (Extended Fig. 3c ). The rest of the CasX protein (630 N-terminal amino acids) showed no detectable similarity to any known protein, suggesting this is a novel class 2 effector. The combination of tracrRNA and separate Cas1, Cas2 and Cas4 proteins is unique among type V systems, and phylogenetic analyses indicate that the Cas1 from the CRISPR-CasX system is distant from those of any other known type V Cas (Extended Data Fig. 3a ). Furthermore, CasX is considerably smaller than any known type V proteins: 980 amino acids compared to a typical size of approximately 1,200 amino acids for Cpf1, C2c1 and C2c3.
To test whether CasX is capable of RNA-guided DNA targeting, analogous to that by Cas9 and Cpf1 proteins, we synthesized a plasmid encoding a minimal CRISPR-CasX locus including casX, a short repeat-spacer array and intervening non-coding regions. We found that when it was expressed in E. coli, this minimal locus blocked transformation by a plasmid bearing a target sequence that we had identified by metagenomic analysis (Fig. 3a -c and Extended Data Fig. 8a, b ). Furthermore, interference with transformation occurred only when the spacer sequence in the mini-locus matched the protospacer sequence in the plasmid target.
To identify a PAM sequence for CasX, we repeated the transformation assay in E. coli using a plasmid containing either a 5′ or 3′ randomized sequence adjacent to the target site. This analysis revealed a stringent preference for the sequence 'TTCN' located 5′ of the protospacer sequence ( Fig. 3d ). No 3′ PAM preference was observed (Extended Data Fig. 8c, d ). Consistent with this finding, we observed that 'TTCA' is the sequence found upstream of the putative Deltaproteobacteria CRISPR-CasX protospacer that was identified in the environmental samples. Notably, both CRISPR-CasX loci share the same PAM sequence, in line with their high degree of protein sequence homology.
Examples of both single-RNA-and dual-RNA-guided systems exist among type V CRISPR loci. We used environmental RNA (metatranscriptomic) data to determine whether CasX requires a trac-rRNA for DNA targeting activity. This analysis revealed a non-coding RNA transcript with sequence complementarity to the CRISPR repeat encoded between the Cas2 open reading frame and the CRISPR array ( Fig. 3e , f). To check for expression of this non-coding RNA in E. coli expressing the CasX locus, we performed northern blots targeted against this transcript in both directions (Extended Data Fig. 8e , f). The results showed expression of a transcript of approximately 110 nucleotides encoded on the same strand as the casX gene, with a more heterogeneous transcript of around 60-70 nucleotides, suggesting that the leader sequence for the CRISPR array lies between the tracrRNA and the array. Transcriptomic mapping further suggests that the crRNA is processed to include around 23 nucleotides of the repeat and 20 nucleotides of the adjacent spacer, similar to the crRNA processing that occurs in CRISPR-Cas9 systems 21, 22 (Fig. 3f ). To determine whether CasX activity depends on the putative tracrRNA, we deleted this region from the minimal CRISPR-CasX locus described above, and repeated the plasmid interference assays. Deletion of the putative tracrRNA-encoding sequence from the CasX plasmid abolished robust transformation interference ( Fig. 3g ). This putative trac-rRNA was joined with the processed crRNA using a tetraloop to form a single-guide RNA (sgRNA) 21 . Although expression using a heterologous promoter of the crRNA alone or a shortened version of the sgRNA did not produce any pronounced plasmid interference, expression of the full-length sgRNA conferred resistance to plasmid transformation ( Fig. 3g ). Together, these results establish CasX as a functional DNAtargeting, dual-RNA-guided CRISPR-associated protein.
We identified another new class 2 Cas protein encoded in the genomes of certain candidate phyla radiation bacteria 6,29 ( Fig. 1 , Extended Data Table 1 ). These bacteria typically have small cell sizes, very small genomes and a limited biosynthetic capacity 6,30-32 , indicating letter reSeArCH that they are most likely to be symbionts 6, [30] [31] [32] [33] . The approximately 1,200 amino acid Cas protein, which we named CasY, appears to be part of a minimal CRISPR-Cas system that includes Cas1 and a CRISPR array ( Fig. 4a ). Most of the CRISPR arrays have unusually short spacers of 17-19 nucleotides, but one system, which lacks Cas1 (CasY.5), has longer spacers (27-29 nucleotides) . No predicted tracrRNA was detected in the vicinity of CRISPR-CasY, based on partial complementarity to the repeat sequences; however, we had insufficient metatranscriptomic data mapped to the CasY loci to detect potential tracrRNA sequences. Thus, from the available data, we cannot exclude the possibility that CasY dependss on a tracrRNA for robust interference.
The six examples of CasY proteins that we identified had no significant sequence similarity to any protein in public databases. A sensitive search using profile Hidden Markov Models (HMMs) 34 built from published Cas proteins 3, 4 indicated that four of the six CasY proteins had local similarities (e values 4 × 10 −11 -3 × 10 −18 ) to C2c3 in the C-terminal region overlapping the RuvC domains and a small region (around 45 amino acids) of the N-terminal region (Extended Data Fig. 3c ). The remaining two CasY proteins had no significant similarity to C2c3 proteins, despite sharing significant sequence similarity (best BLAST hits: e = 6 × 10 −85 , 7 × 10 −75 ) with the other CasY proteins (Supplementary Data 2). C2c3 proteins are putative type V Cas effectors 4 that were identified on short contigs with no taxonomic affiliation, and have not been validated experimentally. Strikingly, both CRISPR-CasY and C2c3 were found next to arrays with short spacers and within loci lacking Cas2, a protein considered essential for integrating DNA into the CRISPR array 9, 35 . It remains to be seen whether these type V systems are functional for spacer acquisition.
Given the low homology of CRISPR-CasY to any experimentally validated CRISPR loci, we wondered whether this system confers RNAguided DNA interference; however, owing to the short spacer length, we did not have reliable information about a possible PAM motif that might be required for such activity. To overcome this, we synthesized the entire CRISPR-CasY.1 locus with a shortened CRISPR array and introduced it into E. coli on a plasmid vector. These cells were then challenged in a transformation assay using a target plasmid with a sequence that matched a spacer in the array and contained an adjacent randomized 5′ or 3′ region to identify a possible PAM. Analysis of transformants revealed depletion of sequences containing a 5′ TA directly adjacent to the targeted sequence ( Fig. 4b ). On the basis of the identified PAM sequence, the CasY.1 locus was overexpressed using a heterologous promoter and tested against plasmids containing single PAMs. Plasmid interference was strongest in the presence of a target containing the identified 5′ TA PAM sequence ( Fig. 4c ). Thus, we conclude that CRISPR-CasY has DNA interference activity.
The systems described here are some of the most compact CRISPR-Cas loci identified to date and are found exclusively in metagenomic datasets. The small number of proteins that are required for interference and their relatively short length make these systems of particular relevance to the development of genome editing tools. Some of these compact loci were identified in organisms with very small genomes and, as a consequence of their small genome size, these organisms probably depend on other community members for basic metabolic requirements, meaning that they have largely remained outside the scope of traditional cultivation-based methods. For CasX and CasY, genomic context is critical for predicting functions that are not evident from unassembled sequence information. Furthermore, the identification of a putative tracrRNA, as well as targeted sequences uncovered through analysis of the genome-resolved metagenomic data, helped to guide functional testing. Notably, we show that metagenomic discoveries related to CRISPR-Cas systems are not restricted to in silico observations, but can be introduced into an experimental setting in which their activity can be analysed. Given that virtually all environments where life exists can now be probed by metagenomic methods, we anticipate that the combined computational-experimental approach will greatly expand the diversity of known CRISPR-Cas systems, enabling the development of new technologies for biological research and clinical applications. CasY.2 (Vogelbacteria) 10 7 Target Non-target For the AMD data, DNA extraction methods and short read sequencing were as described 36, 37 . For the Rifle data, DNA extraction, sequencing, assembly and genome reconstruction were as described 6, 26 . For samples from Crystal Geyser, methods were as described 38, 39 . Rifle metatranscriptomic data were used from ref. 6 .
In brief, DNA was extracted from samples using the PowerSoil DNA Isolation Kit (MoBio Laboratories Inc.). RNA was extracted from 0.2-μ m filters collected from six 2011 Rifle groundwater samples. Following RNA extraction using the Invitrogen TRIzol reagent, DNA was removed with the Qiagen RNase-Free DNase Set and Qiagen Mini RNeasy kits, and cDNA template library was generated using the Applied Biosystems SOLiD Total RNA-Seq kit. DNA was sequenced on Illumina HiSeq2000 platform, and Metatrancriptomic cDNA on 5500XL SOLiD platform after emulsion clonal bead amplification using the SOLiD EZ Bead system (Life Technologies). For the Crystal Geyser data and reanalysis of the AMD data, sequences were assembled using IDBA-UD 40 . DNA and RNA (cDNA) readmapping used to determine sequencing coverage and gene expression, respectively, was performed using Bowtie2 (ref. 41) . Open reading frames were predicted on assembled scaffolds using Prodigal 42 . Scaffolds from the Crystal Geyser dataset were binned on the basis of differential coverage abundance patterns using a combination of ABAWACA 6 , ABAWACA2 (https://github.com/CK7), Maxbin2 (ref. 43) , and tetranucleotide frequency using Emergent Self-Organizing Maps (ESOM) 44 . Genomes were manually curated using per cent GC content, taxonomic affiliation and genome completeness. Scaffolding errors were corrected using ra2.py (https://github.com/christophertbrown). CRISPR-Cas computation analyses. The assembled contigs from the various samples were scanned for known Cas proteins using hidden Markov model (HMM) profiles, which were built using the HMMer suite 34 , based on alignments from refs 3, 4. CRISPR arrays were identified using a local version of the CrisprFinder software 45 . Loci that contained both Cas1 and a CRISPR array were further analysed if one of the ten open reading frames adjacent to the cas1 gene encoded for an uncharacterized protein larger than 800 amino acids, and no known cas interference genes were identified on the same contig. These large proteins were further analysed as potential class 2 Cas effectors. The potential effectors were clustered to protein families based on sequence similarities using MCL 46 . These protein families were expanded by building HMMs representing each of these families, and using them to search the metagenomic datasets for similar Cas proteins. To compare the identified protein families to known proteins, homologues were searched using BLAST 47 against the NCBI non-redundant (nr) and metagenomic (env_nr) protein databases, as well as HMM searches against the UniProt KnowledegeBase 34, 48 . Only proteins with no full-length hits (> 25% of the protein's length) were considered novel proteins. Distant homology searches of the putative Cas proteins were performed using HHpred from the HH-suite 49 . High scoring HHpred hits were used to infer domain architecture based on comparison to solved crystal structures 50, 51 , and secondary structure that was predicted by JPred4 (ref. 52). Protein modelling was performed using Phyre2 (ref. 53 ). The HMM database, including the newly discovered Cas proteins, is available in Supplementary Data 6.
Spacer sequences were determined from the assembled data using CrisprFinder 45 . CRASS 54 was used to locate additional spacers in short DNA reads of the relevant samples. Spacer targets (protospacers) were then identified by BLAST 47 searches (using 'task blastn-short') against the relevant metagenomic assemblies for hits with ≤ 1 mismatch to spacers. Hits belonging to contigs that contained an associated repeat were filtered out (to avoid identifying CRISPR arrays as protospacers). Protospacer adjacent motifs (PAMs) were identified by aligning regions flanking the protospacers and visualized using WebLogo 55 . In cases where one spacer had multiple putative protospacers with different compositions of flanking nucleotides, each distinct combination of protospacer and downstream nucleotides was taken into account for the logo calculation. RNA structures were predicted using mFold 56 . Average nucleotide identity was computed with the pyani Python module (https://github.com/widdowquinn/pyani), using the Mummer 57 method. CRISPR array diversity was analysed by manually aligning spacers, repeats and flanking sequences from the assembled data. Manual alignments and contig visualizations were performed with Geneious 9.1.
For the phylogenetic analyses of Cas1 and Cas9, we used proteins of the newly identified systems along with the proteins from refs 3, 4. A non-redundant set was compiled by clustering together proteins with ≥ 90% identity using CD-HIT 58 . Alignments were produced with MAFFT 59 , and maximum-likelihood phylogenies were constructed using RAxML 60 with PROTGAMMALG as the substitution model and 100 bootstrap samplings. Cas1 tree were rooted using the branch leading to casposons. Trees were visualized using FigTree 1.4.1 (http://tree.bio.ed.ac.uk/ software/figtree/) and iTOL v3(ref. 61 ). Generation of heterologous plasmids. Metagenomic contigs were made into minimal CRISPR interference plasmids by removing proteins associated with acquisition for CRISPR-CasX and reducing the size of the CRISPR array for both CRISPR-CasX and CRISPR-CasY. The minimal locus was synthesized as Gblocks (Integrated DNA Technology). Native promoters were used, with the exception of the overexpression of CasY.1 and expression of the crRNA alone or sgRNA for CasX in Fig. 3g where the J23119 constitutive promoter was used. The minimal CRISPR loci were assembled using Gibson Assembly 62 into a plasmid with a p15A origin of replication and chloramphenicol resistance gene. Detailed plasmid maps are available at the links provided in Supplementary Table 2 . PAM depletion assay. PAM depletion assays were conducted as previously described 63 with modification. Plasmid libraries containing randomized PAM sequences were assembled by annealing a DNA oligonucleotide containing a target with a 7-nucleotide randomized PAM region with a primer (Supplementary Table 2 ) and extended with Klenow Fragment (NEB). The double-stranded DNA was digested with EcoRI and NcoI and ligated into a pUC19 backbone. The ligated library was transformed into E. coli DH5α and > 10 8 cells were harvested and the plasmids extracted and purified. We transformed 200 ng of the pooled library into electrocompetent E. coli harbouring a CRISPR locus or a control plasmid with no locus. The transformed cells were plated on selective medium containing carbenicillin (100 mg l −1 ) and chloramphenicol (30 mg l −1 ) for 30 h at 25 °C. Plasmid DNA was extracted and the PAM sequence was amplified with adapters for Illumina sequencing. The 7-nucleotide PAM region was extracted and PAM frequencies calculated for each 7-nucleotide sequence. PAM sequences depleted above the specified threshold were used to generate a sequence logo with WebLogo 55 . Plasmid interference. Putative targets identified from metagenomic sequence analysis or PAM depletion assays were cloned into a pUC19 plasmid. We transformed 10 ng of target plasmid into electrocompetent E. coli (NEB Stable) containing the CRISPR loci plasmid. CasX.1 was used for the plasmid interference assays under control of native promoters or using a strong heterologous promoter (J23119) for sgRNA and crRNA expression. CasY.1 was put under the control of a heterologous promoter (J23119) for these assays. Cells were recovered for 2 h at 25 °C in super optimal broth and an appropriate dilution was plated on selective media. Plates were incubated at 25 °C and colony forming units were counted. All plasmid interference experiments were performed in triplicate and electrocompetent cells were prepared independently for each replicate. Northern blots. E. coli containing the deltaproteobacteria CasX CRISPR locus was grown to A 600 = 1 at 25 °C in super optimal broth. RNA was extracted by warm phenol extraction, separated on 10% denaturing polyacrylamide gel and blotted as previously described 64 . ARMAN-Cas9 protein expression and purification. Expression constructs for Cas9 from ARMAN-1 (AR1) and ARMAN-4 (AR4) were assembled from gBlocks (Integrated DNA Technologies) that were codon-optimized for E. coli. The assembled genes were cloned into a pET-based expression vector as an N-terminal His 6 -MBP or His 6 fusion protein. Expression vectors were transformed into BL21(DE3) E. coli cells and grown in LB broth at 37 °C. For protein expression, cells were induced during mid-log phase with 0.4 mM IPTG (isopropyl β -d-1-thiogalactopyranoside) and incubated overnight at 16 °C. All subsequent steps were conducted at 4 °C. Cell pellets were resuspended in lysis buffer (50 mM Tris-HCl, 500 mM NaCl, 1 mM TCEP, 10 mM Imidazole, 0.5% Triton X-100; pH 8) and supplemented with Complete protease inhibitor mixture (Roche) before lysis by sonication. Lysate was clarified by centrifugation at 15,000g for 40 min and applied to Superflow Ni-NTA agarose (Qiagen) in batch. The resin was washed extensively with wash buffer A (50 mM Tris-HCl, 500 mM NaCl, 1 mM TCEP, 10 mM imidazole; pH 8) followed by 5 column volumes of wash buffer B (50 mM Tris-HCl, 1 M NaCl, 1 mM TCEP, 10 mM imidazole; pH 8). Protein was eluted off of Ni-NTA resin with elution buffer (50 mM Tris-HCl, 500 mM NaCl, 1 mM TCEP, 300 mM Imidazole; pH 8). The His 6 -MBP tag was removed by TEV protease during overnight dialysis against wash buffer A. Cleaved Cas9 was removed from the affinity tag through a second Ni-NTA agarose column. The protein was dialysed into IEX buffer A (50 mM Tris-HCl, 300 mM NaCl, 1 mM TCEP, 5% glycerol; pH 7.5) before application to a 5-ml Heparin HiTrap column (GE Life Sciences). Cas9 was eluted over a linear NaCl (0.3-1.5 M) gradient. Fractions were pooled and concentrated with a 30-kDa spin concentrator (Thermo Fisher). When applicable, Cas9 was further purified via size-exclusion chromatography on a Superdex letter reSeArCH 200-pg column (GE Life Sciences) and stored in IEX buffer A for subsequent cleavage assays. For yeast expression, AR1-Cas9 was cloned into a Gal1/10 His6-MBP TEV Ura S. cerevisiae expression vector (Addgene plasmid 48305). The vector was transformed into a BY4741 URA3 strain and cultures were grown in synthetic media (5 g l −1 ammonium sulfate, 1.7 g l −1 nitrogen base (Sunrise Science), 0.72 g l −1 complete supplement mixture -ura (Sunrise Science), 20 g l −1 glucose, 1.5% glycerol, 2% lactic acid) at 30 °C. At an A 600 of approximately 0.6, protein expression was induced with 2% (w/v) galactose and incubated overnight at 16 °C. Protein purification was performed as above. RNA in vitro transcription and oligonucleotide purification. In vitro transcription reactions were performed as previously described 65 using synthetic DNA templates containing a T7 promoter sequence. All in vitro transcribed putative guide RNA sequences and target RNA or DNA were purified via denaturing PAGE. Double-stranded target RNA and DNA were hybridized in 20 mM Tris HCl (pH 7.5) and 100 mM NaCl by incubation at 95 °C for 1 min, followed by slow-cooling to room temperature. Hybrids were purified by native PAGE. RNA and DNA sequences used in this study are listed in Supplementary Table 2 . In vitro cleavage assays. Purified DNA and RNA oligonucleotides were radiolabelled using T4 polynucleotide kinase (NEB) and [γ -32P] ATP (Perkin-Elmer) in 1× PNK buffer for 30 min at 37 °C. PNK was heat inactivated at 65 °C for 20 min and free ATP was removed from the labelling reactions using illustra Microspin G-25 columns (GE Life Sciences). CrRNA and tracrRNA were mixed in equimolar quantities in 1× refolding buffer (50 mM Tris HCl pH 7.5, 300 mM NaCl, 1 mM TCEP, 5% glycerol) and incubated at 70 °C for 5 min and then slow-cooled to room temperature. The reactions were supplemented to 1 mM final metal concentration and subsequently heated at 50 °C for 5 min. After slow-cooling to room temperature, refolded guides were placed on ice. Unless noted for buffer or salt concentration, Cas9 was reconstituted with an equimolar amount of guide in 1× cleavage buffer (50 mM Tris HCl pH 7.5, 300 mM NaCl, 1 mM TCEP, 5% glycerol, 5 mM divalent metal) at 37 °C for 10 min. Cleavage reactions were conducted in 1× cleavage buffer with a 10× excess of Cas9-guide complex over radiolabelled target at 37 °C or the indicated temperature. Reactions were quenched in an equal volume of gel loading buffer supplemented with 50 mM EDTA. Cleavage products were resolved on 10% denaturing PAGE and visualized by phosphorimaging. In vivo E. coli interference assays. E. coli transformation assays for ARMAN-1 Cas9 and ARMAN-4 Cas9 were conducted as previously published 66 . Briefly, E. coli transformed with plasmids expressing guide RNA sequences were made electrocompetent. Cells were then transformed with 9 fmol of plasmid encoding wild-type or catalytically inactive Cas9 (dCas9). A dilution series of recovered cells was plated on LB plates with selective antibiotics. Colonies were counted after 16 h at 37 °C. Data Availability. All the sequences reported in this study for the first time have been deposited in NCBI database under BioProject PRJNA349044. The NCBI Nucleotide database accession and coordinates of each locus are specified in Extended Data Table 1 . The BioSample and Sequence Reads Archive (SRA) accessions for the ARMAN-1 spacers and protospacers are detailed in Supplementary  Table 1 . The HMMs used in this study are provided in Supplementary Data 6. All other data are available from the authors upon reasonable request. Fig. 2) and array segments representing locus variants that were reconstructed from the short DNA reads. Variability is due to spacers that were present in only a subset of archaeal cells in the population, as well as spacers whose context differed owing to spacer loss (indicated by black lines). White boxes indicate repeats and coloured arrows indicate CRISPR spacers (spacers with different colours have different sequences, except for unique spacers that are black). In CRISPR systems, spacers are typically added unidirectionally, so the high variety of spacers on the left side is attributed to recent acquisition. ca  s9  |C  AS  -II  -C  |B  ell  iel  la  ba  ltic  a  DS  M  15  88  3  uid  16  81  82  |N  C  01  80  10  |13  52  aa   ca  s9  |C  A  S  -I  I-C  |T  re  po  ne  m  a  pe  di  s  T  A  4  ui  d2  15  71  5|  N  C  02  20  97  |1  28 2a a ca s9 |C A S -I I-C |C or yn eb ac te riu m di ph th er ia e N C T C 13 12 Supplementary Table 2 . Details regarding the organisms and genomic location in which the CRISPR-Cas system were identified, as well as information on the number and average length of reconstructed spacers and the repeat length. ARMAN-1 spacers were reconstructed from 16 samples, see details in Supplementary Table 1 . NA, not available.
